Tixagevimab and Cilgavimab (Evusheld) in Rituximab-treated Antineutrophil Cytoplasmic Antibody Vasculitis Patients

Kidney Int Rep. 2022 Nov;7(11):2537-2538. doi: 10.1016/j.ekir.2022.08.019. Epub 2022 Aug 27.
No abstract available